Phase II Trial of Carboplatin and Bevacizumab for the Treatment of Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial and Spinal Cord Ependymoma in Adults: A Multi-Center Trial
Phase of Trial: Phase II
Latest Information Update: 13 Aug 2018
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin (Primary)
- Indications Ependymoma
- Focus Therapeutic Use
- 03 Aug 2018 Planned number of patients changed from 35 to 46.
- 13 Jul 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.
- 17 Nov 2017 Planned number of patients changed from 46 to 35.